pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 2,216 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
tucatinib
Tukysa (tucatinib)
Metastatic Colorectal Cancer
Seagen Inc
0 catalysts
Marketed
typhoid Vi polysaccharide [strain S typhi Ty2] vaccine
Typhim Vi
Typhoid Fever
Sanofi Pasteur Inc
0 catalysts
Marketed
typhoid [strain salmonella typhi Ty21a] vaccine DR
Vivotif
Typhoid Fever
Bavarian Nordic AS
0 catalysts
← prev
page 73 of 74
next →
131
Pain89
Neurology1
Marketed
ubrogepant
Ubrelvy (ubrogepant)
Migraine
Calcitonin gene-related peptide type 1 receptor
$ABBVAbbVie Inc.
0 catalysts
Marketed
umeclidinium bromide
Incruse Ellipta (umeclidinium bromide)
Chronic Bronchitis
GlaxoSmithKline LLC
0 catalysts
Marketed
uridine triacetate
Xuriden (uridine triacetate)
Mitochondrial Diseases
BTG International Inc
0 catalysts
Marketed
urofollitropin
Bravelle (urofollitropin)
Anovulation
Ferring Pharmaceuticals Inc
0 catalysts
Marketed
valbenazine
Valbenazine (valbenazine)
Tardive Dyskinesia
Lupin Ltd
0 catalysts
Marketed
valoctocogene roxaparvovec
Roctavian (valoctocogene roxaparvovec)
Hemophilia A (Factor VIII Deficiency)
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Marketed
valrubicin
Valstar (valrubicin)
Bladder Carcinoma
Endo Pharmaceuticals Inc
0 catalysts
Marketed
valsartan
Valsartan (valsartan)
Cardiovascular Risk Factors
Square Pharmaceuticals PLC
0 catalysts
Marketed
vamorolone
Agamree (vamorolone)
Becker Muscular Dystrophy
Glucocorticoid receptorMineralocorticoid receptor
ReveraGen BioPharma Inc
0 catalysts
Marketed
vancomycin hydrochloride
Vancomycin Hydrochloride (vancomycin hydrochloride)
Bacterial Endocarditis
Samson Medical Technologies LLC
0 catalysts
Marketed
vardenafil hydrochloride ODT
Vardenafil Hydrochloride (vardenafil hydrochloride)
Erectile Dysfunction
Macleods Pharma USA Inc
0 catalysts
Marketed
varicella [strain Oka] vaccine
Varivax
Chicken Pox
$MRKMerck & Co., Inc.
0 catalysts
Marketed
varicella zoster immune globulin (human)
Varizig (varicella zoster immune globulin (human))
Chicken Pox
$KMDAKAMADA LTD
0 catalysts
Marketed
varicella zoster vaccine
Shingrix
Herpes Zoster (Shingles)
GlaxoSmithKline LLC
0 catalysts
Marketed
vasopressin
Vasostrict (vasopressin)
Hypotension
Par Pharmaceutical Inc
0 catalysts
Marketed
velaglucerase alfa
Vpriv (velaglucerase alfa)
Gaucher Disease Type I
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
velmanase alfa
Lamzede (velmanase alfa-tycv)
Alpha-Mannosidosis
Chiesi USA Inc
0 catalysts
Marketed
vemurafenib
Zelboraf (vemurafenib)
Hairy Cell Leukemia
Serine/threonine-protein kinase B-raf
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
venlafaxine ER
Venbysi XR (venlafaxine [INN])
Generalized Anxiety Disorder (GAD)
Almatica Pharma LLC
0 catalysts
Marketed
venlafaxine hydrochloride
Venlafaxine Hydrochloride (venlafaxine hydrochloride)
Major Depressive Disorder
Modavar Pharmaceuticals LLC
0 catalysts
Marketed
vericiguat
Verquvo (vericiguat)
Systolic Heart Failure (HFrEF)
Merck Sharp & Dohme LLC
0 catalysts
Marketed
vestronidase alfa
MepseVII (vestronidase alfa-vjbk)
Mucopolysaccharidosis VII (MPS VII) (Sly Syndrome )
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
Marketed
vibegron
Gemtesa (vibegron)
Overactive Bladder
Sumitomo Pharma America Inc
0 catalysts
Marketed
vilazodone hydrochloride
Viibryd (vilazodone hydrochloride)
Major Depressive Disorder
Allergan Sales LLC
0 catalysts
Marketed
viloxazine hydrochloride ER
Qelbree (viloxazine hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
$SUPNSUPERNUS PHARMACEUTICALS, INC.
0 catalysts
Marketed
viltolarsen
Viltepso (viltolarsen)
Duchenne Muscular Dystrophy
NS Pharma Inc
0 catalysts
Marketed
vimseltinib
Romvimza (vimseltinib)
Graft Versus Host Disease (GVHD)
Ono Pharmaceutical Co Ltd
0 catalysts